Pharmafile Logo

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

December 1, 2025 |  

- PMLiVE

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.

Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come. 

Among the proven benefits of Medscape AI:

  • Reliability: Clinically Vetted Sources, Transparent By Design
    • Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
    • AI responses are traceable, transparent, and supported by citations 
  • Recency: Always Current and Continuously Updated
    • Integrates verified real-time news, research updates, and guideline changes
    • Daily and weekly editorial oversight ensures outputs reflect the latest evidence 
  • Relevance: Aligned to Practice and Patient Care
    • Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
    • Synthesized insights tuned to each specialty, workflow, and clinical context
    • Guidance supports differential diagnosis, treatment decisions, and next-step care
    • Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools  
  • Time-Saving Clinical Efficiency
    • Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature

“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”

Medscape  is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month. 

 Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!

Educational Symposia

Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.

  • Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
    • Time: 11:30 AM – 1:00 PM ET
    •  Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK
  • Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
    • Time: 11:30 AM – 1:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International DEFG 
  • Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
    • Time: 11:30 AM – 1:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
    • Time: 3:30 PM – 5:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
    • Time: 3:30 PM – 5:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK

ASH Abstract Publication 

Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood

For more information, please contact Jelena Spyropoulos.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Putting Skin in the Game at AAD 2023

AAD has wrapped up in New Orleans, and the Medscape team have returned home from another successful conference.During the conference, Medscape hosted one educational symposium, Reframing the Management Approach for...

Wrapping up EAU with a Look at Medscape’s Urology Impact

The Medscape Education Global team has returned from EAU in Milan, Italy, having presented an educational symposium and a networking event with Urology faculty and supporters.The educational symposium, Harnessing the...

Medscape’s Commitment to Health Equity and Women’s Health

Women's health is a topic of increasing importance and interest among the medical community. Beyond impacting the individual patient, women's health is a public health issue in communities around the...

Medscape Education Demonstrates Deep Cardiology Outcomes Expertise at ACC 2023

As cardiologists from around the world return home from New Orleans and ACC 2023, Medscape Education is looking back at a successful conference.At this year’s event, the Medscape Education team...

Rare Diseases on Medscape Education: Pustular Psoriasis

Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Watch this video to understand a patient's journey with pustular psoriasis.To learn more about Medscape's rare...

Rare Diseases on Medscape Education: Long-Chain Fatty Acid Oxidation Disorder

Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Listen to a mother explain her daughter's journey with a long-chain fatty acid oxidation disorder.To...

Medscape Expands Global Reach with Acquisition of Health Information Platform Grupo SANED

WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, today announced that it has acquired Grupo SANED, Spain's leader in...

Medscape Oncology: Delivering Impact at ASH

You can read more information on Medscape Oncology at ASH here, or please reach out to Chris Carey or Steve Dunn who can tell you more about how Medscape can help to...

Medscape Oncology: Delivering Impact at ASH

Medscape Oncology was on-site in New Orleans at ASH 2022. During the 4-day conference, Medscape Oncology hosted educational symposia, interacted with clinicians at our booth, and worked with leading faculty...

Medscape Education: Rare Diseases PAH

Today is Rare Disease Day, February 28.Hear from Helen as she describes in her own words what it’s like to live with PAH, and her perspective as a patient.  To learn...